DEC 04, 2021 12:00 PM PST

Modulating the CBD/Apelinergic System Interaction as a COVID-19 Treatment?

WRITTEN BY: Nadine Husami

Although CBD has long been implicated as an anti-inflammatory agent, it is only within the past few decades that it has gained experimental evidence in support of such effects.

Notably, previous work published in Cannabis and Cannabinoid Research uncovered a potential role for CBD in ameliorating clinical symptoms of acute respiratory distress syndrome (ARDS) via cytokine storm regulation.

In extreme cases of respiratory viral infection – such as in severe cases of COVID-19 – massive pulmonary inflammation and enhanced inflammatory responses within the bronchoalveolar units of lower respiratory tracks result in a cytokine storm that leads to ARDS development.  

In this initial study, a murine model of ARDS was developed and then used to investigate whether CBD treatment was able to alleviate ARDS-like symptoms associated with COVID-19 (including “low oxygen saturation, lymphopenia, elevated frequencies of neutrophils/monocytes, excess production of pro-inflammatory cytokines, and destruction of lung morphology”) following simulated viral infection with synthetic RNA.

Based on the results of this preliminary study – using the aforementioned murine ARDS model – the researchers sought to delve further into interrogating the therapeutic potential of CBD in the context of viral respiratory infections.  

Published in the Journal of Cellular and Molecular Medicine, their follow-up study interrogated the mechanism responsible for modulating CBD’s previously observed anti-viral properties. ARDS-like symptoms were induced via simulated viral infection with a synthetic double-stranded RNA (dsRNA) analog, polyinosinic:polycytidylic acid (Poly(I:C)).

12-week-old adult male C57B1 mice randomly split into three experimental groups (n = 10 mice/group) received either one of the following treatments (once daily intranasal administration over three days): Group 1 = sterile saline [control]; Group 2 = Poly(I:C) [emulates ARDS]; and Group 3 = Poly(I:C) but also received additional intraperitoneal CBD treatment (3 doses total administered at designated time-points).

At the study’s onset and throughout its duration, researchers measured blood oxygen saturation in the carotid arteries of all mice with a portable pulse oximeter. Blood and lung tissue that were harvested following sacrifice underwent flow cytometry, immunofluorescence (IF), and histological analyses (fluorescence imaging, bright field microscopy, and Masson’s Trichrome staining of collagen fibers on fixed lung tissue sections).

Whole blood and lung tissues from Poly(I:C)-treated mice demonstrated pathologic features of ARDS as well as marked reductions in apelin expression relative to the controls. The additional CBD treatment in Group 3 mice appeared to alleviate ARDS symptoms by restoring inflammatory homeostasis (increased T cells / decreased neutrophils, perivascular and peri-bronchiolar histopathological changes). Notably, CBD treatment also increased apelin expression in Group 3 mice towards levels comparable to the controls.

Apelin is an endogenous ligand that also acts as a second catalytic substrate for the receptor recognized by the SARS-CoV2 spike protein, the angiotensin-converting enzyme 2 (ACE2) receptor. It is also a ligand for APJ (a G protein-coupled receptor) – an interaction collectively referred to as the apelinergic system.

From these results, the authors concluded that a potential interaction between the apelinergic system and CBD is likely responsible for CBD’s observed anti-inflammatory effects. This most recent study, along with their previous work, provide encouraging evidence that modulating this interaction harbors the potential to improve COVID-19 patient outcomes.

 

Sources: Cannabis and Cannabinoid Research; NIH National Cancer Institute; Journal of Cellular and Molecular Medicine; Annals of the New York Academy of Sciences

 

About the Author
  • Nadine (She/Her) is a Cannabis Sciences category writer at Labroots. She received her BSc in Biotechnology from Niagara University, where she investigated the use of bacterial glycoside hydrolases for the production of universal blood via hydrolytic ABO antigen cleavage. She also performed cannabis research during her undergraduate career as a laboratory associate for a plant genetics biotechnology company. She is currently a Biochemistry PhD in training at the University at Buffalo; her current thesis work investigates the role of long noncoding RNAs in ocular pathologies.
You May Also Like
JUL 08, 2021
Cannabis Sciences
High-potency Cannabis Impacts Memory, but not Decision-Making
JUL 08, 2021
High-potency Cannabis Impacts Memory, but not Decision-Making
High-potency cannabis products impair memory in various ways, according to new research published in Scientific Rep ...
OCT 08, 2021
Cannabis Sciences
The Synergistic Mystery of the Entourage Effect
OCT 08, 2021
The Synergistic Mystery of the Entourage Effect
The entourage effect is a much talked about characteristic attributed with the unique psychoactive effects associated wi ...
NOV 23, 2021
Health & Medicine
No Short Term Effects of THC-positive Breast Milk
NOV 23, 2021
No Short Term Effects of THC-positive Breast Milk
A recent study found that THC does not have short-term negative effects on an early, premature baby’s health. Rese ...
NOV 30, 2021
Cannabis Sciences
Terpene-Mediated Modulation of Cannabinoid Activity
NOV 30, 2021
Terpene-Mediated Modulation of Cannabinoid Activity
A popular theory – the “entourage effect” – has been gaining traction amongst the cannabis scien ...
JAN 07, 2022
Health & Medicine
Heavy Metal Contamination in Cannabis
JAN 07, 2022
Heavy Metal Contamination in Cannabis
A recent meta-analysis of research studies published in Toxin Reviews found that cannabis plant absorption of heavy meta ...
JAN 20, 2022
Cannabis Sciences
Cannabinoids Bind Spike Proteins of SARS-CoV-2 & Emerging Variants to Prevent Infection in vitro
JAN 20, 2022
Cannabinoids Bind Spike Proteins of SARS-CoV-2 & Emerging Variants to Prevent Infection in vitro
As the pandemic has progressed, multiple variants of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) have e ...
Loading Comments...